Literature DB >> 2254314

Evidence that both Ca(2+)-specific sites of skeletal muscle TnC are required for full activity.

Z Sheng1, W L Strauss, J M Francois, J D Potter.   

Abstract

To investigate the role of the Ca2(+)-specific (I and II) sites of fast skeletal muscle troponin C (TnC) in the regulation of contraction, we have produced two TnC mutants which have lost the ability to bind Ca2+ at either site I (VG1) or at site II (VG2). Both mutants were able to partially restore force to TnC-depleted skinned muscle fibers (approximately 25% for VG1 and approximately 50% for VG2). In contrast, bovine cardiac TnC (BCTnC), which like VG1 binds Ca2+ only at site II, could fully reactivate the contraction of TnC-depleted fibers. Higher concentrations of both mutants were required to restore force to the TnC-depleted fibers than with wild type TnC (WTnC) or BCTnC. VG1 and VG2 substituted fibers could not bind additional WTnC, indicating that all of the TnC-binding sites were saturated with the mutant TnC's. The Ca2+ concentration required for force activation was much higher for VG1 and VG2 substituted fibers than for WTnC or BCTnC substituted fibers. Also, the steepness of force activation was much less in VG1 and VG2 versus WTnC and BCTnC substituted fibers. These results suggest cooperative interactions between sites I and II in WTnC. In contrast, BCTnC has essentially the same apparent Ca2+ affinity and steepness of force activation as does WTnC. Thus, cardiac TnC must have structural differences from WTnC which compensate for the lack of site I, while in WTnC, both Ca2(+)-specific sites are probably crucial for full functional activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2254314

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  The role of the Ca(2+) regulatory sites of skeletal troponin C in modulating muscle fibre reactivity to the Ca(2+) sensitizer bepridil.

Authors:  P Kischel; B Bastide; J D Potter; Y Mounier
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

Review 2.  Molecular mechanism of troponin-C function.

Authors:  Z Grabarek; T Tao; J Gergely
Journal:  J Muscle Res Cell Motil       Date:  1992-08       Impact factor: 2.698

3.  Wrongly citing literature.

Authors:  J D Potter; W G Kerrick
Journal:  J Muscle Res Cell Motil       Date:  1992-06       Impact factor: 2.698

4.  Effects of cardiac thin filament Ca2+: statistical mechanical analysis of a troponin C site II mutant.

Authors:  Q Huynh; C A Butters; J M Leiden; L S Tobacman
Journal:  Biophys J       Date:  1996-03       Impact factor: 4.033

5.  Kinetics of contractile activation in voltage clamped frog skeletal muscle fibers.

Authors:  P Szentesi; Z Papp; G Szücs; L Kovács; L Csernoch
Journal:  Biophys J       Date:  1997-10       Impact factor: 4.033

6.  Differential effects of bepridil on functional properties of troponin C in slow and fast skeletal muscles.

Authors:  P Kischel; L Stevens; Y Mounier
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

7.  Functional characterization of the two isoforms of troponin C from the arthropod Balanus nubilus.

Authors:  C C Ashley; T J Lea; P E Hoar; W G Kerrick; P F Strang; J D Potter
Journal:  J Muscle Res Cell Motil       Date:  1991-12       Impact factor: 2.698

8.  Fast pressure jumps can perturb calcium and magnesium binding to troponin C F29W.

Authors:  David S Pearson; Darl R Swartz; Michael A Geeves
Journal:  Biochemistry       Date:  2008-10-23       Impact factor: 3.162

9.  Intra- and interdomain effects due to mutation of calcium-binding sites in calmodulin.

Authors:  Liang-Wen Xiong; Quinn K Kleerekoper; Xu Wang; John A Putkey
Journal:  J Biol Chem       Date:  2010-01-04       Impact factor: 5.157

10.  The role of troponin C in the length dependence of Ca(2+)-sensitive force of mammalian skeletal and cardiac muscles.

Authors:  J Gulati; E Sonnenblick; A Babu
Journal:  J Physiol       Date:  1991-09       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.